e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD
M. Jones, E. Evans (Swansea, United Kingdom)
Source:
Annual Congress 2007 - Exacerbations of COPD
Session:
Exacerbations of COPD
Session type:
Thematic Poster Session
Number:
3313
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Jones, E. Evans (Swansea, United Kingdom). Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD. Eur Respir J 2007; 30: Suppl. 51, 3313
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The importance of C-reactive protein in patients with acute exacerbation of severe COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD
Source: Eur Respir J 2015; 45: 76-86
Year: 2015
Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD
Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Year: 2010
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015
Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015
COPD, asthma and C-reactive protein
Source: Eur Respir J 2006; 27: 874-876
Year: 2006
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006
Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Procalcitonin and C-reactive protein levels in infective attacks of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003
Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: ERS Lung Science Conference 2021
Year: 2021
C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006
C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept